YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investing.com -- Gerresheimer AG (ETR:GXIG) shares rose on Wednesday after the German pharmaceutical packaging and drug-delivery group reported a sharp sequential improvement in second-quarter adjusted EBITDA and said it expects a stronger…
Company Logo Opportunities center on sterile, high-barrier and smart packaging for biologics and injectables; automated production; compliant, traceable formats; and localized manufacturing, diversified sourcing and resilient supply chains…
Gerresheimer (XTRA:GXI) has moved back into focus after announcing agreements to sell its Centor and Primary Packaging Plastics businesses for about €1.5b, alongside preliminary Q1 2026 results and an ongoing transformation program. Over t…
This article first appeared on GuruFocus. Revenue: Slightly increased by EUR5 million year-over-year in Q1 2026. EBITDA: Decreased by EUR15 million year-over-year to EUR66 million in Q1 2026. Free Cash Flow before M&A: Improved significant…
Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, Will Assume his Duties Until Further Notice DUSSELDORF, GERMANY - August 24, 2026 (NEWMEDIAWIRE) - Uwe Rohrhoff has stepped down from his role as interim CEO of Gerreshei…
DUESSELDORF, GERMANY and ZHENJIANG DAGANG, CHINA - July 23, 2026 (NEWMEDIAWIRE) - Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industries, has started operations at a new…
DUSSELDORF, GERMANY - July 9, 2026 (NEWMEDIAWIRE) - Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech, and cosmetics industries, has published its first voluntary separate Non-financial Re…
DUSSELDORF, GERMANY - June 29, 2026 (NEWMEDIAWIRE) - Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech, and cosmetics industries, today published its 2025 annual and consolidated financial…
This article first appeared on GuruFocus. Revenue: EUR2.3 billion, up by EUR330 million, primarily driven by the acquisition of Bormioli. Organic Revenue Growth: Approximately flat at 0.3%. Adjusted EBITDA Margin: 16.8%, within the guidanc…
(Bloomberg) -- After storied Austrian motorcycle manufacturer KTM AG presented an insolvency plan to creditors last year, several of them convened a video conference to discuss a counter-proposal. More than 100 parties joined, but none of…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. What stands out about Gerresheimer right now Gerresheimer (XTRA:GXI) has been drawing attention after sharp share price swings, wit…
The collaboration combines Newel Health's H-Core platform, regulated digital medical devices, and AI capabilities with Gerresheimer's drug delivery and primary packaging expertise, extended through digital health solutions and established…
Company Logo The Middle East and Africa wearable injectors market is poised for growth, driven by increasing chronic disease prevalence and healthcare advancements. Key opportunities include rising demand for self-administration devices, e…
Company Logo The global prefilled syringes market is forecasted to grow from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%. Key growth drivers include the rising prevalence of chronic diseases such as diabetes a…
Last September, Gerresheimer's stock plunged after German regulators announced an investigation into potential accounting rule violations and compliance irregularities. The packaging maker's issues started when BaFin, Germany’s federal fin…
Gerresheimer AG (OTC:GRRMY) is one of the 12 Takeover Rumors Targeted by Short Sellers. Gerresheimer AG (OTC:GRRMY) is one of the takeover rumors targeted by short sellers. On April 17, 2026, Reuters reported that Gerresheimer had rejected…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Gerresheimer’s analyst price target picture has shifted sharply, wi…
Company Logo The United States nutraceutical packaging market is projected to grow from US$ 1.54 billion in 2025 to US$ 2.12 billion by 2033, driven by a CAGR of 4.11%. Key growth factors include the rise of e-commerce, demand for eco-frie…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Gerresheimer (XTRA:GXI) is Under Intense Scrutiny Right Now Ger…
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held Gerresheimer AG (ETR:GXI) for five whole…
Key Insights Given the large stake in the stock by institutions, Gerresheimer's stock price might be vulnerable to their trading decisions The top 14 shareholders own 51% of the company Using data from analyst forecasts alongside ownership…
View Comments
Recent analyst revisions have led to a decrease in the consensus price target for Gerresheimer stock, dropping from €37.84 to €34.62. This change reflects analysts’ reassessment of the company’s fair value in light of ongoing market uncert…
Gerresheimer AG's (ETR:GXI) earnings announcement last week didn't impress shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive underlying factors. AI is about to change h…
BERLIN (Reuters) -Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations. Watchdog BaFin said it would review Ge…
Shares in the pharmaceutical equipment manufacturer slumped as much as 38% after Germany’s financial watchdog said it had violated accounting regulations. Continue Reading View Comments
BERLIN (Reuters) -Shares in medical equipment maker Gerresheimer plunged as much as 38% on Wednesday after Germany's financial regulator said it was investigating suspected accounting rule violations. Watchdog BaFin said it would review Ge…
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. By way of learning-by-doing, we'll look…
View Comments
By Jesus Calero and Elviira Luoma (Reuters) -Shares in Novo Nordisk rose as much as 14% on Thursday after trial data from Eli Lilly's experimental weight-loss pill fell short of expectations, boosting investor confidence in the Danish drug…
Explore Gerresheimer's Fair Values from the Community and select yours Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. To wit, the Gerresheimer AG (ETR:GXI) share price man…
The market for Gerresheimer AG's (ETR:GXI) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem. We've found 21 US stocks that are forecast to pay a di…
Key Insights The projected fair value for Gerresheimer is €53.81 based on 2 Stage Free Cash Flow to Equity With €48.08 share price, Gerresheimer appears to be trading close to its estimated fair value Analyst price target for GXI is €70.50…
While Gerresheimer AG (ETR:GXI) might not have the largest market cap around , it led the XTRA gainers with a relatively large price hike in the past couple of weeks. Shareholders may appreciate the recent price jump, but the company still…
Key Insights Institutions' substantial holdings in Gerresheimer implies that they have significant influence over the company's share price 52% of the business is held by the top 13 shareholders Ownership research along with analyst foreca…
Gerresheimer AG's (ETR:GXI) recent weak earnings report didn't cause a big stock movement. However, we believe that investors should be aware of some underlying factors which may be of concern. Our free stock report includes 4 warning sign…